In a study of 1052 Chinese breast cancer patients in Hong Kong, 53% and 61.6% of pre- and postmenopausal women were ER-positive, respectively, and 51.5% and 46.2% were PR-positive, respectively [21]. Here, ESR1 is linked to breast carcinoma.